Report
Bruno de La Rochebrochard

EUROFINS SCIENTIFIC Q3 revenue broadly in line with estimates. 2019 and 2020 guidance upgraded

Q3 revenue broadly in line with estimates. 2019 and 2020 guidance upgraded
Q3 revenue broadly in line with our estimate
After significant recent acquisitions signed or close to be completed, 2019 and 2020 guidance have been upgraded
Fewer acquisitions in the next two year with a strict control of financials
Underlying
Eurofins Scientific Societe Europeenne

Eurofins Scientific is an international life sciences company operating in food & pharmaceutical products testings. Co. provides analytical testing services to clients from various industries including pharmaceutical, food, and environmental sectors. Co. offers analytical methods for evaluating the authenticity, origin, safety, identity, composition, and purity of biological substances & products. Co. verifies authenticity of products analyzed to detect dangerous components (pathogens, prions, pesticides, asbestos, mycotoxins, dioxins, toxic substances, etc.). Co. operates in Benelux, France, Germany, North America, Scandinavia, British Isles (U.K. & Republic of Ireland), & other countries.

Provider
Bryan Garnier
Bryan Garnier

Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.

Analysts
Bruno de La Rochebrochard

Other Reports on these Companies
Other Reports from Bryan Garnier

ResearchPool Subscriptions

Get the most out of your insights

Get in touch